HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Michael Grossman Selected Research

Therapeutics

1/2023The Relationship Between Hospital Stroke Center Designation and TVT Reported Stroke: The Michigan TAVR Experience.
1/20171-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
3/2016Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement.
12/2015If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease.
5/2013Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention.
12/2012The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.
6/2011Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.
3/2007Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience.
1/2006Cellular and molecular therapeutic modalities for arterial obstructive syndromes.
11/2002Management of intermittent claudication.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Michael Grossman Research Topics

Disease

7Peripheral Arterial Disease
02/2016 - 01/2006
5Stroke (Strokes)
01/2023 - 10/2002
5Myocardial Infarction
01/2018 - 10/2002
5Anemia
01/2018 - 12/2010
4Aortic Valve Stenosis (Aortic Stenosis)
01/2019 - 03/2016
3Heart Failure
06/2017 - 12/2010
3Chronic Limb-Threatening Ischemia
06/2017 - 03/2007
3Hemorrhage
12/2010 - 06/2009
3Vascular Diseases (Vascular Disease)
01/2006 - 10/2003
2Endocarditis
01/2023 - 01/2021
2Pathologic Constriction (Stenosis)
01/2017 - 11/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2013 - 03/2002
2Cardiovascular Diseases (Cardiovascular Disease)
06/2011 - 07/2009
2Pain (Aches)
04/2011 - 12/2010
2ST Elevation Myocardial Infarction
02/2010 - 06/2009
2Mitral Valve Insufficiency (Mitral Regurgitation)
08/2004 - 02/2003
1Body Weight (Weight, Body)
06/2017
1Sarcopenia
03/2016
1Frailty
03/2016
1Renal Insufficiency (Renal Failure)
01/2016
1Chronic Obstructive Pulmonary Disease (COPD)
01/2016
1Aneurysm (Aneurysms)
04/2015
1Abdominal Aortic Aneurysm
04/2015
1Arteriovenous Fistula
04/2011
1Hematoma
04/2011
1Thrombosis (Thrombus)
04/2011
1False Aneurysm (Pseudoaneurysm)
04/2011
1Acute Kidney Injury (Acute Renal Failure)
09/2008
1Diabetes Mellitus
05/2007
1Hypoxia (Hypoxemia)
03/2007
1Hyperemia
09/2006
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2006
1Left Ventricular Dysfunction
01/2006
1Ischemia
07/2005
1Ventricular Remodeling
02/2003

Drug/Important Bio-Agent (IBA)

3CreatinineIBA
06/2017 - 12/2010
2Heparin (Liquaemin)FDA LinkGeneric
01/2016 - 12/2010
1A-factor (Streptomyces)IBA
01/2023
1Warfarin (Coumadin)FDA LinkGeneric
01/2016
1Clopidogrel (Plavix)FDA Link
04/2015
1Hemoglobins (Hemoglobin)IBA
07/2009
1Contrast MediaIBA
07/2009
1ORALIT (ORS)IBA
06/2009
1Glycoproteins (Glycoprotein)IBA
06/2009
1Abciximab (ReoPro)FDA Link
06/2009
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
09/2008
1MetalsIBA
05/2007
1Etoposide (VP 16)FDA LinkGeneric
03/2007
1Transcription Factors (Transcription Factor)IBA
03/2007
1Acetylcholine (Acetylcholine Chloride)FDA Link
09/2006
1Angiogenic ProteinsIBA
01/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005
1Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2004
1CytokinesIBA
02/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2003
1Proteins (Proteins, Gene)FDA Link
03/2002

Therapy/Procedure

11Therapeutics
01/2023 - 10/2002
6Percutaneous Coronary Intervention
05/2013 - 10/2003
5Transcatheter Aortic Valve Replacement
01/2023 - 03/2016
3Blood Transfusion (Blood Transfusions)
01/2016 - 07/2009
2Contraindications
01/2023 - 01/2021
2Surgical Amputation (Amputations)
01/2018 - 06/2011
2Surgical Instruments (Clip)
01/2017 - 06/2016
2Stents
05/2007 - 11/2002
1Length of Stay
06/2017
1Prostheses and Implants (Prosthesis)
01/2017
1Aftercare (After-Treatment)
03/2016
1Catheters
03/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2016
1Endovascular Procedures
04/2015
1Endovascular Aneurysm Repair
04/2015
1Limb Salvage
04/2011
1Vascular Surgical Procedures
12/2010
1Thrombectomy
02/2010
1Drug-Eluting Stents
05/2007